OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurology Neurosurgery and Psychiatry is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
091 The East London Parkinson’s disease project – engaging a diverse population in research	138
175 A case series of anti-HMGCR immune mediated necrotizing myopathy: the West Midlands data	123
102 Levodopa and melanoma what do clinicians think?	107
117 Who is the culprit – the virus or the anti-virus?	102
Haemorrhagic myelitis as a manifestation of MOG antibody-associated disease	86
35 Processing speed (PS) improvement in alcohol related brain damage (ARBD)	85
Navigating the presymptomatic frontier in genetic ALS and FTD	82
086 Long-term efficacy of fremanezumab in migraine patients with inadequate response to prior preventive medication classes	80
West is best – a strongman with numb feet	76
12 A pilot investigation of interoceptive accuracy, awareness, and sensibility in functional neurological disorder	75
059 Cannabidiol in refractory adult epilepsies: broadening the Lennox-Gastaut phenotype?	70
Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts	69
Multiple sclerosis reactivations after fingolimod discontinuation for pregnancy planning	67
101 Motor and non-motor features of prodromal PD	62
Neural (re)organisation of language and memory: implications for neuroplasticity and cognition	60
Sodium valproate is associated with cortical thinning of disease-specific areas in juvenile myoclonic epilepsy	56
Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis	55
High frequency ofHTRA1ANDABCC6mutations in Japanese patients with adult-onset cerebral small vessel disease	54
Improved naming in patients with Broca’s aphasia with tDCS	53
Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohort	53
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis	52
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis	50
Early treatment of type II SMA slows rate of progression of scoliosis	50
DNA methylation profiling in central nervous system tumours	48
Characterising ALS disease progression according to El Escorial and Gold Coast criteria	48

The Scottish Epilepsy Deaths Study Score (SEDS Score): a risk prediction model for epilepsy-related deaths	47
005 A case of xanthomatous hypophysitis presenting as recurrent pituitary adenoma	47
40 Temporal discounting and male depression	47
052 SKYLINE study design efficacy and safety of gantenerumab in participants at-risk for Alzheimer’s disease	47
178 Motor neurone disease and sociodemographic factors: a review	46
066 The Utility of 18-FDG PET imaging in the preoperative workup for epilepsy surgery	44
Evaluation of MDS-PSP diagnostic criteria in a combined behavioural neurology and atypical parkinsonism service	44
055 Assessment of MACE cognitive screener using efficiency indexes	43
009 Asymmetric peri-optic cerebrospinal fluid space distension in cluster headache	42
132 Adverse prognostic factors predicting disease modifying therapies in MS: a real- world cohort	41
106 Critical ischaemia without infarction presenting as progressive hemichorea: a case study and literature review	41
Risk of stroke in multiple sclerosis and neuromyelitis optic spectrum disorder: a Nationwide cohort study in South Korea	40
Dissociative seizures in the emergency room: room for improvement	40
Genetics of inherited peripheral neuropathies and the next frontier: looking backwards to progress forwards	40
Multicentre validation of a patient-reported outcome measure for functional movement disorders	39